Cover Image

A validated LCâMS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study

Liquid chromatographyâtandem mass spectrometry (LCâMS/MS) method was used for simultaneous quantification of tolterodine and its metabolite 5-hydroxy methyl tolterodine in rat plasma. Tolterodine-d6 and 5-hydroxy methyl tolterodine-d14 were used as internal standards (IS). Chromatographic separation...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rihana Parveen Shaik (Author), Srinivasa Babu Puttagunta (Author), Chandrasekhar Bannoth Kothapalli (Author), Bahlul Zayed Sh. Awen (Author), B.R. Challa (Author)
Format:	Book
Published:	Elsevier, 2013-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bioanalytical method development and validation of milnacipran in rat plasma by LCâMS/MS detection and its application to a pharmacokinetic study
by: Kanchanamala Kanala, et al.
Published: (2013)

Application of LCâMS/MS for quantitative analysis of glucocorticoids and stimulants in biological fluids
by: Jamshed Haneef, et al.
Published: (2013)

LCâUV and LCâMS evaluation of stress degradation behavior of desvenlafaxine
by: Shubhangi M. Pawar, et al.
Published: (2012)

Development of an LCâMS/MS method for determination of 2-oxo-clopidogrel in human plasma
by: Yu-Han Li, et al.
Published: (2015)

LC, MSn and LCâMS/MS studies for the characterization of degradation products of amlodipine
by: Ravi N. Tiwari, et al.
Published: (2015)

Simultaneous determination of atorvastatin, metformin and glimepiride in human plasma by LCâMS/MS and its application to a human pharmacokinetic study
by: Srinivasa Rao Polagani, et al.
Published: (2013)

Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LCâMS/MS to support a bioequivalence study
by: Ajay Gupta, et al.
Published: (2013)

Simultaneous determination of telmisartan and amlodipine in human plasma by LCâMS/MS and its application in a human pharmacokinetic study
by: Vasu Babu Ravi, et al.
Published: (2012)

Precolumn derivatization LCâMS/MS method for the determination and pharmacokinetic study of glucosamine in human plasma and urine
by: Min Song, et al.
Published: (2012)

Quantification of tolvaptan in rabbit plasma by LC-MS/MS: Application to a pharmacokinetic study
by: Kumar S. Moola, et al.
Published: (2015)

Selective separation, detection of zotepine and mass spectral characterization of degradants by LCâMS/MS/QTOF
by: M.V.N. Kumar Talluri, et al.
Published: (2014)

Quantification of sibutramine and its two metabolites in human plasma by LCâESI-MS/MS and its application in a bioequivalence study
by: Venkata Suresh Ponnuru, et al.
Published: (2012)

Establishment of inherent stability of pramipexole and development of validated stability indicating LCâUV and LCâMS method
by: Shubhangi M. Pawar, et al.
Published: (2013)

LCâMS/MS assay for the determination of natamycin in rabbit and human plasma: Application to a pharmacokinetics and protein binding study
by: Yashpal Singh Chhonker, et al.
Published: (2013)

Determination of ergocalciferol in human plasma after Diels-Alder derivatization by LCâMS/MS and its application to a bioequivalence study
by: Pritesh Contractor, et al.
Published: (2017)

Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LCâMS/MS: Method development, validation and application to pharmacokinetics
by: Xiao-Jiao Li, et al.
Published: (2013)

Simultaneous determination of asenapine and valproic acid in human plasma using LCâMS/MS: Application of the method to support pharmacokinetic study
by: Ambavaram Vijaya Bhaskar Reddy, et al.
Published: (2013)

Method development and validation for naratriptan determination in human plasma by HPLC with tandem mass spectrometry detection, and its application to bioequivalence study
by: Balasekhara Reddy Challa, et al.
Published: (2011)

Validated LCâMS/MS method for simultaneous determination of SIM and its acid form in human plasma and cell lysate: Pharmacokinetic application
by: Tamer A. Ahmed, et al.
Published: (2012)

Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LCâMS(/MS): Applications to selected cardiovascular drugs
by: Yahya R. Tahboub
Published: (2014)

Quantification of 17-desacetyl norgestimate in human plasma by liquid chromatographyâtandem mass spectrometry (LCâMS/MS) and its application to bioequivalence study
by: Ashish Saxena, et al.
Published: (2015)

Simultaneous pharmacokinetic assessment of cefadroxil and clavulanic acid in human plasma by LCâMS and its application to bioequivalence studies
by: Janaki Sankarachari Krishnan Nagarajan, et al.
Published: (2013)

Determination of cefcapene acid by LCâMS and their application to a pharmacokinetic study in healthy Chinese volunteers
by: Hong-Fei Duan, et al.
Published: (2013)

LCâMS/MS determination and pharmacokinetic study of bergenin, the main bioactive component of Bergenia purpurascens after oral administration in rats
by: Bao-Hong Li, et al.
Published: (2013)

Method development and validation of Guanfacine in rat plasma by liquid chromatographyâtandem mass spectrometry: Application to a pharmacokinetic study
by: Suryanarayana Murthy Goparaju, et al.
Published: (2013)

Development and validation of a high throughput LCâMS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma andÂ itsÂ application to a pharmacokinetic study
by: Pinaki Sengupta, et al.
Published: (2017)

Comparison of conventional and supported liquid extraction methods for the determination of sitagliptin and simvastatin in rat plasma by LCâESIâMS/MS
by: B. Ramesh, et al.
Published: (2015)

Quantification of desloratadine in human plasma by LC-ESI-MS/MS and application to a pharmacokinetic study
by: Venkata Suresh Ponnuru, et al.
Published: (2012)

Development of a sensitive and rapid method for quantitation of (S)-(â)- and (R)-(+)-metoprolol in human plasma by chiral LCâESIâMS/MS
by: Primal Sharma, et al.
Published: (2014)

LCâUV/MS quality analytics of paediatric artemether formulations
by: Kirsten Vandercruyssen, et al.
Published: (2014)

Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LCâESI-MS/MS and its application to pharmacokinetics in rats
by: Shankar Ganesh Gadepalli, et al.
Published: (2014)

Determination of asenapine in presence of its inactive metabolites in human plasma by LC-MS/MS
by: Nirav P. Patel, et al.
Published: (2018)

Metabolic profiling of plasma from cardiac surgical patients concurrently administered with tranexamic acid: DI-SPMEâLCâMS analysis
by: Barbara Bojko, et al.
Published: (2014)

Effect of Baicalein on the Pharmacokinetics of Cilostazol and Its Two Metabolites in Rat Plasma Using UPLC-MS/MS Method
by: Qinghua Weng, et al.
Published: (2022)

A high throughput method for Monitoring of Sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma
by: Er-Min Gu, et al.
Published: (2022)

Simultaneous Determination of Parecoxib and Its Metabolite Valdecoxib Concentrations in Beagle Plasma by UPLC-MS/MS and Application for Pharmacokinetics Study
by: Li S, et al.
Published: (2020)

Development and validation of UPLC-MS/MS method for icariin and its metabolites in mouse urine
by: Na Li, et al.
Published: (2024)

Pharmacokinetic Study and Metabolite Identification of CAM106 in Rats by Validated UHPLC-MS/MS
by: Ruqi Xi, et al.
Published: (2023)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLCâMS/MS
by: Nejal M. Bhatt, et al.
Published: (2015)

Highly sensitive LC-MS/MS method to estimate doxepin and its metabolite nordoxepin in human plasma for a bioequivalence study
by: Nirav P. Patel, et al.
Published: (2018)